141 related articles for article (PubMed ID: 30453153)
1. Generation of an iPSC line, INMi001-A, carrying the two most common USH2A mutations from a compound heterozygote with non-syndromic retinitis pigmentosa.
Sanjurjo-Soriano C; Erkilic N; Manes G; Dubois G; Hamel CP; Meunier I; Kalatzis V
Stem Cell Res; 2018 Dec; 33():228-232. PubMed ID: 30453153
[TBL] [Abstract][Full Text] [Related]
2. Generation of a human iPSC line, INMi005-A, from a patient with non-syndromic USH2A-associated retinitis pigmentosa.
Sanjurjo-Soriano C; Erkilic N; Vache C; Dubois G; Roux AF; Meunier I; Kalatzis V
Stem Cell Res; 2022 Apr; 60():102738. PubMed ID: 35248879
[TBL] [Abstract][Full Text] [Related]
3. Generation of a human iPSC line, INMi002-A, carrying the most prevalent USH2A variant associated with Usher syndrome type 2.
Sanjurjo-Soriano C; Erkilic N; Manes G; Dubois G; Hamel CP; Meunier I; Kalatzis V
Stem Cell Res; 2018 Dec; 33():247-250. PubMed ID: 30468996
[TBL] [Abstract][Full Text] [Related]
4. Generation of an induced pluripotent stem cell line (FRIMOi002-A) from a retinitis pigmentosa patient carrying compound heterozygous mutations in USH2A gene.
Riera M; Patel A; Corcostegui B; Chang S; Corneo B; Sparrow JR; Pomares E
Stem Cell Res; 2019 Mar; 35():101386. PubMed ID: 30685615
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a human iPSC line, IISHDOi004-A, from a patient with Usher syndrome associated with the mutation c.2276G>T; p.Cys759Phe in the USH2A gene.
Zurita-Díaz F; Ortuño-Costela MDC; Moreno-Izquierdo A; Galbis L; Millán JM; Ayuso C; Garesse R; Gallardo ME
Stem Cell Res; 2018 Aug; 31():152-156. PubMed ID: 30096711
[TBL] [Abstract][Full Text] [Related]
6. Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations.
Dulla K; Slijkerman R; van Diepen HC; Albert S; Dona M; Beumer W; Turunen JJ; Chan HL; Schulkens IA; Vorthoren L; den Besten C; Buil L; Schmidt I; Miao J; Venselaar H; Zang J; Neuhauss SCF; Peters T; Broekman S; Pennings R; Kremer H; Platenburg G; Adamson P; de Vrieze E; van Wijk E
Mol Ther; 2021 Aug; 29(8):2441-2455. PubMed ID: 33895329
[TBL] [Abstract][Full Text] [Related]
7. Generation of an induced pluripotent stem cell (iPSC) line from a patient with autosomal dominant retinitis pigmentosa due to a mutation in the NR2E3 gene.
Terray A; Slembrouck A; Nanteau C; Chondroyer C; Zeitz C; Sahel JA; Audo I; Reichman S; Goureau O
Stem Cell Res; 2017 Oct; 24():1-4. PubMed ID: 29034877
[TBL] [Abstract][Full Text] [Related]
8. Generation of two human induced pluripotent stem cell lines from patients with biallelic USH2A variants.
Zhu T; Wu S; Sun Z; Wei X; Han X; Zou X; Sui R
Stem Cell Res; 2021 Aug; 55():102502. PubMed ID: 34419747
[TBL] [Abstract][Full Text] [Related]
9. Generation and Genetic Correction of USH2A c.2299delG Mutation in Patient-Derived Induced Pluripotent Stem Cells.
Liu X; Lillywhite J; Zhu W; Huang Z; Clark AM; Gosstola N; Maguire CT; Dykxhoorn D; Chen ZY; Yang J
Genes (Basel); 2021 May; 12(6):. PubMed ID: 34070435
[TBL] [Abstract][Full Text] [Related]
10. Generation of two induced pluripotent stem cell lines from a patient with compound heterozygous mutations in the USH2A gene.
McLenachan S; Wong EYM; Zhang X; Leith F; Moon SY; Zhang D; Chen SC; Thompson JA; McLaren T; Lamey T; De Roach JN; Atlas MD; Dilley RJ; Chen FK
Stem Cell Res; 2019 Apr; 36():101420. PubMed ID: 30904819
[TBL] [Abstract][Full Text] [Related]
11. Establishment and characterization of an iPSC line (FRIMOi001-A) derived from a retinitis pigmentosa patient carrying PDE6A mutations.
Riera M; Patel A; Corcostegui B; Chang S; Sparrow JR; Pomares E; Corneo B
Stem Cell Res; 2019 Mar; 35():101385. PubMed ID: 30685614
[TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of the human iPSC line CABi001-A from a patient with retinitis pigmentosa caused by a novel mutation in PRPF31 gene.
de la Cerda B; Díez-Lloret A; Ponte B; Vallés-Saiz L; Calado SM; Rodríguez-Bocanegra E; Garcia-Delgado AB; Moya-Molina M; Bhattacharya SS; Díaz-Corrales FJ
Stem Cell Res; 2019 Apr; 36():101426. PubMed ID: 30921587
[TBL] [Abstract][Full Text] [Related]
13. Visual Prognosis in USH2A-Associated Retinitis Pigmentosa Is Worse for Patients with Usher Syndrome Type IIa Than for Those with Nonsyndromic Retinitis Pigmentosa.
Pierrache LH; Hartel BP; van Wijk E; Meester-Smoor MA; Cremers FP; de Baere E; de Zaeytijd J; van Schooneveld MJ; Cremers CW; Dagnelie G; Hoyng CB; Bergen AA; Leroy BP; Pennings RJ; van den Born LI; Klaver CC
Ophthalmology; 2016 May; 123(5):1151-60. PubMed ID: 26927203
[TBL] [Abstract][Full Text] [Related]
14. Whole-exome sequencing revealed two novel mutations in Usher syndrome.
Koparir A; Karatas OF; Atayoglu AT; Yuksel B; Sagiroglu MS; Seven M; Ulucan H; Yuksel A; Ozen M
Gene; 2015 Jun; 563(2):215-8. PubMed ID: 25834954
[TBL] [Abstract][Full Text] [Related]
15. Generation of a human iPSC line from a patient with retinitis pigmentosa caused by mutation in PRPF8 gene.
Lukovic D; Bolinches-Amorós A; Artero-Castro A; Pascual B; Carballo M; Hernan I; Erceg S
Stem Cell Res; 2017 May; 21():23-25. PubMed ID: 28677533
[TBL] [Abstract][Full Text] [Related]
16. Generation of an iPS cell line via a non-integrative method using urine-derived cells from a patient with USH2A-associated retinitis pigmentosa.
Guo Y; Zeng Q; Liu S; Yu Q; Wang P; Ma H; Shi S; Yan X; Cui Z; Xie M; Xue Y; Zha Q; Li Z; Zhang J; Tang S; Chen J
Stem Cell Res; 2018 May; 29():139-142. PubMed ID: 29660607
[TBL] [Abstract][Full Text] [Related]
17. Visual Outcomes in Japanese Patients with Retinitis Pigmentosa and Usher Syndrome Caused by USH2A Mutations.
Nagase Y; Kurata K; Hosono K; Suto K; Hikoya A; Nakanishi H; Mizuta K; Mineta H; Minoshima S; Hotta Y
Semin Ophthalmol; 2018; 33(4):560-565. PubMed ID: 28678594
[TBL] [Abstract][Full Text] [Related]
18. Novel deletions involving the USH2A gene in patients with Usher syndrome and retinitis pigmentosa.
García-García G; Aller E; Jaijo T; Aparisi MJ; Larrieu L; Faugère V; Blanco-Kelly F; Ayuso C; Roux AF; Millán JM
Mol Vis; 2014; 20():1398-410. PubMed ID: 25352746
[TBL] [Abstract][Full Text] [Related]
19. Generation of a human iPS cell line from a patient with retinitis pigmentosa due to EYS mutation.
Calado SM; Garcia-Delgado AB; De la Cerda B; Ponte-Zuñiga B; Bhattacharya SS; Díaz-Corrales FJ
Stem Cell Res; 2018 Dec; 33():251-254. PubMed ID: 30471616
[TBL] [Abstract][Full Text] [Related]
20. The effect of the common c.2299delG mutation in USH2A on RNA splicing.
Lenassi E; Saihan Z; Bitner-Glindzicz M; Webster AR
Exp Eye Res; 2014 May; 122():9-12. PubMed ID: 24607488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
